You are here: Industry Insights > GlobalData

News List

India’s CMO market is hotbed for global PE investment: GlobalData expresspharma
August 18, 2020
Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small molecule API hotspots such as in the US and China.
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData expresspharma
August 17, 2020
The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent.
Licensing agreement deals decline in rare diseases space, says report europeanpharmaceuticalreview
August 12, 2020
New research has shown that complex collaborations and partnerships are increasing, while licensing agreements are decreasing in the rare disease space.
mRNA vaccines the most promising among emerging COVID-19 vaccines: Poll pharmaceutical-technology
August 12, 2020
Vaccination is being considered as the only way the coronavirus pandemic can be controlled, although a highly effective vaccine is not expected to be available in less than a year.
Success of indigenous COVID-19 vaccines will make access easy and affordable in India: GlobalData expresspharma
August 12, 2020
India is making rapid progress in the development of indigenous COVID-19 vaccines. With an increase in the number of COVID-19 positive cases, their success will make access easy and affordable for Indians, says GlobalData, data and analytics company.
Licensing agreement deals decline in rare diseases space: GlobalData expresspharma
August 10, 2020
Big pharma companies are searching for innovative biotechs to invest in the rare diseases space.
Healthcare industry reports 95 deals worth $4.9 billion in July 2020 expresspharma
August 10, 2020
Deal value decreased by 40 per cent in July 2020, compared to June 2020, informs a report from GlobalData.
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData expresspharma
August 04, 2020
Both drugs have seen a sharp decline in price since the availability of the first generic in India.
COVID-19 resurgence expected in US as herd immunity unlikely: GlobalData expresspharma
August 03, 2020
New data suggest that some hard-hit communities may be better protected for COVID-19 resurgence, while other communities are not.
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData expresspharma
July 31, 2020
Biocon plans to create a comprehensive digital therapeutics portfolio by extending its Insulia platform to its complete range of insulin products.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page